Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ESGR | Ordinary Shares | Options Exercise | $2.96M | +20K | +31.5% | $147.75 | 83.5K | Dec 8, 2023 | Direct | F1, F2 |
transaction | ESGR | Ordinary Shares | Disposed to Issuer | -$5.7M | -20K | -23.95% | $285.14 | 63.5K | Dec 8, 2023 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ESGR | Cash-Settled Stock Appreciation Right | Options Exercise | $0 | -20K | -100% | $0.00* | 0 | Dec 8, 2023 | Ordinary Shares | 20K | $147.75 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | Exercise of the Cash-Settled Stock Appreciation Rights (the "SARs") is reported as the simultaneous purchase and sale to the issuer of the number of ordinary shares for which the SARs were exercised. Pursuant to their terms, the SARs were only exercisable in cash and the reporting person did not receive any ordinary shares. |
F2 | Includes 13,465 Restricted Share Units that vest in three approximately equal annual installments beginning on March 20, 2024. |
F3 | The SARs are settled in cash, and the reporting person will not receive issuer ordinary shares upon exercise. |